Buy (150 RUB)
Generate QR code
Open Access
Subscription or Fee Access
Therapy of anxiety-depressive syndrome with xenon
https://doi.org/10.33667/2078-5631-2024-33-23-25
Abstract
A comparative study on the treatment of anxiety-depressive syndrome with xenon, including 60 patients. To assess the effectiveness of xenon therapy, the patients were divided into 2 groups of 30 people: the main group and the control group. The first group received anti-anxiety drugs and antidepressants of the SSRI group and 5 xenotherapy procedures for 10 days, while the control group received only anti-anxiety drugs and antidepressants. The groups were comparable in age, gender, and severity of anxiety and depressive symptoms. In patients receiving xenon inhalation in addition to drug therapy, there was a better regression of both anxiety and depressive complaints after five sessions of xenon therapy.
About the Authors
L. G. Geybatova
Dagestan State Medical University
Russian Federation
Russian Federation
Geybatova Laura G., PhD Med, associate professor at Dept of Neurology of Faculty of Advanced Studies and Professional Retraining of Specialists
Makhachkala
M. F. Magomaev
Dagestan State Medical University
Russian Federation
Russian Federation
Magomaev Magomed F., DM Sci (habil.), associate professor at Depat of Neurology of Faculty of Advanced Studies and Professional Retraining of Specialists
Makhachkala
S. M. Magomaeva
Dagestan State Medical University
Russian Federation
Russian Federation
Magomaeva Saadat M., 4th year student of Faculty of Medicine
Makhachkala
References
1. Erichev A.N., Morgunova A.M. Sovremennye stressovye situatsii i vozniknovenie chuvstva trevogi. Kak nauchitsya borotsya. / Prakticheskoe rukovodstvo. SPb: Izd.dom. SPb MAPO, 2009. 30 s. (In Russ.). ISBN9785980371319.
2. Kaplan H.I., Sadock B.J., Grebb J.A. Synopsis of Psychiatry. 1994. P. 911-912. ISBN9781975145569/
3. Nutt D.J., Mazilia A. Br.J. Psychiatry. 2001; 179: 390-397. https://doi.org/10.1192/bjp.179.5.390
4. Krishnan K.R., Delong M., Kraemer H. et al. Comorbidity of depression with other medical diseases in the elderly. Biol. Psychiatry. 2002; 52 (6): 559-88. https://doi.org/10.1016/s0006–3223 (02) 014725
5. Simon G.E., VonKorff M., Piccinelli M. et al. An international study of the relation between somatic symptoms and depression. N. Engl. J. Med. 1999; 341 (18): 1329-35. https://doi.org/10.1056/NEJM199910283411801
6. Fedotova A.V. Anxiety-depressive disorders in general clinical practice. Rational Pharmacotherapy in Cardiology. 2008; 4 (3): 83-88. (In Russ.). https://doi.org/10.20996/1819-6446-2008-4-3-83-88
7. Neznanov N.G., Petrova N.N. Kachestvo zhizni kak mera otsenki effektivnosti reabilitatsii bolnykh. V: Psikhosotsialnaya reabilitatsiya i kachestvo zhizni: Sbornik nauchnykh trudov. SPb.: SPbNIPNI im. V.M. Bekhtereva, 2001. S. 301-11.
8. Onayon M. Epidemiologiia narusheniia tsirkadiannykh ritmov pri depressii (rasshirennyi referat). Psikhiatriia i psikhofarmakoterapiia 2007; 9 (3): 52-7. (In Russ.).
9. Wells R., Stewart K., Hays R. et al. The functioning and well-being of depressed patients: the results of the Medical Outcome Study. JAMA. 1989; 262 (7): 914-9. https://doi.org/10.1001/jama.1989.03430070062031
10. Chaudhury D., Liu H., Han M.N. Neuronal correlates of depression. Cell Mol. Life. Sci. 2015; 72 (24): 25-48. https://doi.org/10.1007/s0001801520446.
11. Damir E.A., Burov N.E., Makeev G.N., Dzhabarov D. Narkoticheskie svoystva ksenona i perspektivy ego primeneniya v anesteziologii. Anestez. i reanimatol. 1996; 1 (71-75). (In Russ.). ISSN1609-1175.
12. Ksenon v anesteziologii: Kliniko-eksperim. issled. / N.E. Burov, V.N. Potapov, G.N. Makeev. Moskva: Puls, 2000. ISBN5934860062
13. Dickenson A.H., Sullivan A.F. Evidence for a role of the NMDA receptor in the frequency dependent potentiation of deep rat dorsal horn nociceptive neurones following C fibre stimulation. Neuropharmacology. 1987; 26 (8): 1235-1238. https://doi.org/10.1016/0028-3908 (87) 902759
14. Coderre T.J. The role of excitatory amino acid receptors and intracellular messengers in persistent nociception after tissue injury in rats. Molecular Neurobiology. 1993; 7 (3-4): 229-246. https://doi.org/10.1007/BF02769177.
Review
For citations:
Geybatova L.G., Magomaev M.F., Magomaeva S.M. Therapy of anxiety-depressive syndrome with xenon. Medical alphabet. 2024;(33):23-25. (In Russ.) https://doi.org/10.33667/2078-5631-2024-33-23-25
Views:
195
Email this article 